Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home News

The World First OTC Certified Covid-19 Antigen Oral Fluid Test!

I'm Online Chat Now
China Hangzhou AllTest Biotech CO.,LTD certification
China Hangzhou AllTest Biotech CO.,LTD certification
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

Company News
The World First OTC Certified Covid-19 Antigen Oral Fluid Test!
Latest company news about The World First OTC Certified Covid-19 Antigen Oral Fluid Test!

HANGZHOU ALLTEST BIOTECH CO.,LTD said that is recently received Europe CE OTC certificate for its COVID-19 Antigen Rapid Test (oral fluid) for self testing, and is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens present in human oral fluid.

 

This test is designed for home use with self-collected oral fluid samples in individuals who are suspected of COVID-19. The strengths of OTC COVID-19 Antigen Rapid Test (saliva) are EASY (specimen collection), FAST (results in 15 minutes assay time), SIMPLE (operation, no equipment required), and HIGH ACCURACY.

 

The OTC COVID-19 Antigen Rapid Test (saliva) obtain a preliminary results only, the final confirmation should be based on clinical diagnostic results. Results are for the detection of SARS-CoV-2 nucleocapsid protein antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19.

 

A clinical evalution was conducted comparing the results obtained the COVID-19 Antigen Rapid Test with RT-PCR test results. The clinical trial included 406 oral fluid specimens. According to ALLTEST, the test results demonstrated 99.3% specificity and 90.1% sensitivity with an overall accuracy of 97.0%. The observed accuracy may vary depending on the prevalence of the virus in the population.

 

ALLTEST provide a complete solution for COVID-19 diagnosis, which is providing multiple choices of reliable COVID-19 rapid tests (both Antigen and IgG/IgM antibody tests) in time. Located in Hangzhou Economic and Technologic Development Area, P.R China.

Pub Time : 2021-06-08 14:32:40 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: +86 13989889852

Fax: 86-571-56267856

Send your inquiry directly to us